FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue ...
Southwest Airlines expects slower pace of cost increases, but inflation persists
Southwest (LUV) said that it still faces pressure from inflation but that its cost per available seat mile excluding fuel and special items (CASM-X) will cool from a rate of 11.1% in the fourth ...